A498 Cells

A498 cells are a human renal cell carcinoma cell line derived from the kidney tissue of a 58-year-old Caucasian male. These cells are extensively used in research related to kidney cancer, particularly for studying clear cell renal cell carcinoma, which is the most common type of kidney cancer in adults. The A498 cell line is characterized by its epithelial-like morphology and has been a valuable model for investigating the molecular and cellular mechanisms of renal carcinogenesis. These cells exhibit several features typical of kidney cancer, including alterations in the expression of genes involved in cell cycle regulation, apoptosis, and angiogenesis. A498 cells are particularly useful for examining the metabolic pathways altered in kidney cancer, as they display a distinct metabolic profile that includes changes in lipid and glucose metabolism. This aspect makes them suitable for metabolic targeting studies, which explore how altering metabolic pathways can inhibit tumor growth. Furthermore, A498 cells are employed in drug discovery and toxicology studies to test the efficacy of new chemotherapeutic agents and targeted therapies. They are also used to study the response of renal cancer cells to hypoxic conditions-a common feature of solid tumors that significantly influences tumor behavior and treatment response. Overall, the A498 cell line serves as an essential tool in renal cancer research, facilitating the development of more effective therapeutic strategies and enhancing our understanding of kidney cancer biology.